3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sezary Syndrome
1
Sarcoma
1
Paget Disease, Extramammary
1
Neurofibromatosis 1
1
Neurofibromatoses
1
Neurofibroma
1
Mycosis Fungoides
1
Muir-Torre Syndrome
1
Microcystic adnexal carcinoma
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Eccrine Porocarcinoma
1
Carcinoma, Signet Ring Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Basosquamous
1
Carcinoma, Basal Cell
1
Adenocarcinoma, Papillary
1
Interventions
Cisplatin
4
Cetuximab
4
pembrolizumab
3
Radiotherapy
3
cemiplimab
2
Surveys and Questionnaires
2
Magnetic Resonance Spectroscopy
2
Carboplatin
2
olaparib
1
niraparib
1
fludarabine
1
dostarlimab
1
calcipotriene
1
avelumab
1
atezolizumab
1
alpha-2'-deoxythioguanosine
1
aldesleukin
1
Watchful Waiting
1
Tiragolumab
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Platinum
1
Phlebotomy
1
Paclitaxel
1
Nivolumab
1
Lidocaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
talimogene laherparepvec
×
30 days
×
Clear all
No trials found.